AVE avecho biotechnology limited

the positive side if elixia launch ?fails?, page-8

  1. 5,317 Posts.
    lightbulb Created with Sketch. 252
    $10-12 mil from tiny sales per outlet. This is my base/worst case scenario.


    TL, this is indeed a worst/base case scenario. In fact if anyone want's to take me up I'd make a symbolic wager of few pints of lager that revenue of that order will be achieved no later than year's end and that is only the pointy end of the spear.

    I'd estimate that by the end of 2012, revenues from the cellulite cream alone will exceed $100 million annually and sales will still be growing.

    This is the cash cow that will fund everything else that this company wants to do.

    Ditto Calzada; they are also looking at the same cellucreme-funded scenario. And their share price has been reflecting this - tripling since last October. POH will do the same once the dummies stop selling cheap.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $11.10M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $1.335K 381.5K

Buyers (Bids)

No. Vol. Price($)
44 33957138 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 8218985 6
View Market Depth
Last trade - 11.13am 07/07/2025 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.